Osceola Creates Company to Combine Compounders

Osceola Creates Company to Combine Compounders

Osceola Capital has partnered with industry veteran Jacob Beckel to launch Revelation Pharma as a platform investment to begin a consolidation of the 503A pharmacy compounding sector. As it begins its consolidation, Revelation Pharma will target 503A compounding pharmacies that have annual revenue of at least $1.5 million and EBITDA of at least $250K. Sub […]